Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | GABRG2 | P18507 | 2/20 | 1.00 |
| ▸ | GABRB3 | P28472 | 2/20 | 1.00 |
| ▸ | GABRA5 | P31644 | 2/20 | 1.00 |
| ▸ | GABRA3 | P34903 | 2/20 | 1.00 |
| ▸ | GABRA2 | P47869 | 2/20 | 1.00 |
| ▸ | GABRA6 | Q16445 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.40 |
| ▸ | GABRE | P78334 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL10512593 | 0.97 | GABRA1 (0.95) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| Hydrochloric Acid SCHEMBL27668420 | 0.97 | GABRA1 (0.95) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| Iodomethane SCHEMBL14858600 | 0.93 | GABRA1 (0.86) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| Methylamine SCHEMBL190522 | 0.91 | GABRA1 (0.82) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| Propane SCHEMBL27497477 | 0.91 | GABRA1 (0.82) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| SCHEMBL3101278 | 0.84 | — | — | |
| SCHEMBL4620125 | 0.78 | TSHR (0.63) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| SCHEMBL5212 | 0.78 | — | — | |
| SCHEMBL739246 | 0.78 | GABRA1 (0.64) | GABRA1TSHRGABRG2GABRB3GABRA5 | |
| Hydrochloric Acid SCHEMBL443213 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 645 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087536-A1 | METHODS OF USING HOMOTAURINE AND ANALOGS THEREOF FOR THE TREATMENT OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST INDUCED GASTROINTESTINAL SIDE EFFECTS | UNIVERSITY OF TARTU (EE) | 2026-04-30 | — | — | WO | claimed |
| EP-4725480-A1 | RAMAN SPECTROSCOPY FOR PERSONALIZED CANCER MEDICINE | Endress+Hauser Process Analysis Support SARL (FR) | 2026-04-15 | — | — | EP | claimed |
| EP-4520324-A1 | COMPOSITION COMPRISING A TAURINE TRANSPORTER (TAUT) INHIBITOR AND 5-AMINOLEVULINIC ACID (5-ALA), ITS USE IN TREATING CANCER CELL TUMORS, AND ANALYSIS OF THE EFFECTIVENESS OF THE COMPOSITION | Endress+Hauser Process Analysis Support SARL (FR) | 2025-03-12 | — | — | EP | claimed |
| US-20240390311-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-28 | — | — | US | claimed |
| EP-4405049-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS | The Regents of the University of California (US) | 2024-07-31 | — | — | EP | claimed |
| US-20230381125-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-11-30 | — | — | US | claimed |
| EP-4217002-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS | The Regents of the University of California (US) | 2023-08-02 | — | — | EP | claimed |
| WO-2023101899-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING SJOGREN'S SYNDROME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-08 | — | — | WO | claimed |
| CN-115651185-B | Viscosity regulator for oil field and preparation method and application thereof | 山东科兴化工有限责任公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2023048781-A1 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-30 | — | — | WO | claimed |
| WO-2000051590-A2 | NEUROPHARMACOLOGICAL TREATMENT OF SLEEP-RELATED BREATHING DISORDERS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2000-09-08 | — | — | WO | claimed |
| US-6077839-A | ADMINISTERING OPTHALMIC SOLUTION COMPRISING GAMMA AMINOBUTYRIC ACID AGONIST COMPOUNDS | ALLERGAN SALES, INC. (US) | 2000-06-20 | — | — | US | claimed |
| EP-0789567-A4 | A METHOD FOR TREATING VASCULAR HEADACHES | GEN HOSPITAL CORP (US) | 1999-01-13 | — | — | EP | claimed |
| EP-0789567-A1 | A METHOD FOR TREATING VASCULAR HEADACHES | THE GENERAL HOSPITAL CORPORATION (US) | 1997-08-20 | — | — | EP | claimed |
| US-5587509-A | Caged caboxyl compounds and use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1996-12-24 | — | — | US | claimed |
| WO-1996015782-A1 | A METHOD FOR TREATING VASCULAR HEADACHES | THE GENERAL HOSPITAL CORPORATION (US) | 1996-05-30 | — | — | WO | claimed |
| US-5430175-A | Caged carboxyl compounds and use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-07-04 | — | — | US | claimed |
| WO-1995015305-A1 | CAGED CARVOXYL COMPOUNDS AND THEIR USE IN CHEMICAL KINETIC INVESTIGATION OF NEUROTRANSMITTER RECEPTORS | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-06-08 | — | — | WO | claimed |
| EP-0630240-A1 | METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF GAMMA AMINOBUTYRIC ACID (GABA) AGONISTS | ALLERGAN, INC. (US) | 1994-12-28 | — | — | EP | claimed |
| WO-1993018762-A2 | METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF GAMMA AMINOBUTYRIC ACID (GABA) AGONISTS | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | claimed |